Jaxwest8: Assessment of novel compounds (L-DOPA) to inhibit the onset and progression of Parkinsonian pathology in an acute model of Parkinson's Disease using C57BL/6J male mice (2009)

Jackson Laboratory   With: Yang Y, Rodriguez T

Jaxwest8 downloads
Click on "Download" link or button below, to see the available downloads for this project.
Institutional authorship Jackson Laboratory     Lab web site
Participants Yang Y, Rodriguez T
ContactYan Yang     yan.yang@jax.org     Lab web site
AffiliationJAX In Vivo Services
Project type One-strain study
MPD identifiersJaxwest8     MPD:328
Data changelog No updates/corrections.       Initial release date: 06/2009.
Formatted citation
Click above to copy-paste the entire citation for this MPD web page.

Purpose: The objective of this study was to assess the therapeutic potential of a novel compound (L-DOPA) to inhibit the onset and progression of cell loss and development of Parkinsonian pathology in an acute model of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson Disease using using 9-wk-old C57BL/6J male mice.

By posting this data, JAX® In Vivo Services contributes to community research resources and fulfills an agreement with clients to make normative data public.

Investigator's notes and website:

Compound evaluation services: Chronic MPTP Model of Parkinson’s Disease

Available download:  


Data: Jaxwest8.xls